Back to results
US 10,851,164 B2Granted
Anti-SIRPα antibodies
AssigneeAduro Biotech Holdings, Europe B.V.
InventorsHans Van Eenennaam, Andrea Van Elsas, Erik Voets, Paul Vink, David Lutje Hulsik
Life of this patent
Estimating the term…
Abstract
The present invention relates to anti-SIRPα antibodies, as well as use of these antibodies in the treatment of diseases such as cancer and infectious disease.
Claims19
An antibody or antigen binding fragment thereof that binds to human SIRPαV1 having the sequence of SEQ ID NO:
- 34 with an EC50 between 4.83 nM and 0.022 nM, wherein the antibody or antigen binding fragment comprises each of:
- a. a heavy chain variable region CDR1 comprising the amino acid sequence SYWMH (SEQ ID NO:69),
- b. a heavy chain variable region CDR2 comprising the amino acid sequence AIYPVNNDTTYNQKFKG (SEQ ID NO:70), AIYPVNSDTTYNQKFKG (SEQ ID NO:
- 136) or ALYPVNSDTTYNQKFKG (SEQ ID NO:
- 137),
- c. a heavy chain variable region CDR3 comprising the amino acid sequence SFYYSLDAAWFVY (SEQ ID NO:71),
- d. a light chain variable region CDR1 comprising the amino acid sequence RASQDIGSRLN (SEQ ID NO:72),
- e. a light chain variable region CDR2 comprising the amino acid sequence ATSSLDS (SEQ ID NO:73), and
- f. a light chain variable region CDR3 comprising the amino acid sequence LQYASSPFT (SEQ ID NO:74),
- or wherein the antibody or antigen binding fragment comprises each of:
- g. a heavy chain variable region CDR1 comprising the amino acid sequence NYYIH (SEQ ID NO:1),
- h. a heavy chain variable region CDR2 comprising the amino acid sequence WIYPGNVNTKYNEKFKA (SEQ ID NO:2),
- i. a heavy chain variable region CDR3 comprising the amino acid sequence PTIIATDFDV (SEQ ID NO:3),
- j. a light chain variable region CDR1 comprising the amino acid sequence KASQGVGTAVG (SEQ ID NO:4),
- k. a light chain variable region CDR2 comprising the amino acid sequence WASTRHT (SEQ ID NO:5), and
- l. a light chain variable region CDR3 comprising the amino acid sequence QQYSTYPFT (SEQ ID NO:6).
13 more elements
Dependencies are inferred from the claim text.